tamofen 20 mg tabletti
bayer oy - tamoxifeni citras - tabletti - 20 mg - tamoksifeeni
loxentia 20 mg enterokapseli, kova
krka, d.d., novo mesto - duloxetine hydrochloride - enterokapseli, kova - 20 mg - duloksetiini
loxentia 40 mg enterokapseli, kova
krka, d.d., novo mesto - duloxetine hydrochloride - enterokapseli, kova - 40 mg - duloksetiini
actilyse 2 mg injektio/infuusiokuiva-aine, liuosta varten
boehringer ingelheim international gmbh - alteplase - injektio/infuusiokuiva-aine, liuosta varten - 2 mg - alteplaasi
methotrexat accord 2.5 mg tabletti
accord healthcare b.v. - methotrexate - tabletti - 2.5 mg - metotreksaatti
methotrexat accord 10 mg tabletti
accord healthcare b.v. - methotrexate - tabletti - 10 mg - metotreksaatti
zynquista
guidehouse germany gmbh - sotagliflozin - diabetes mellitus, type 1 - diabeetilla käytettävät lääkkeet - zynquista on tarkoitettu lisänä hoidolla parantamaan glukoositasapainoa aikuisilla tyypin 1 diabetes mellitus-potilailla, joiden painoindeksi (bmi) ≥ 27 kg/m2, joka ei ole saavutettu riittävää glukoositasapainoa huolimatta optimaalinen hoidolla.
thiotepa riemser
esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiset aineet - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - antineoplastiset aineet - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.
rybrila 160 mikrog/ml oraaliliuos
clinigen healthcare b.v. - glycopyrronium bromide - oraaliliuos - 160 mikrog/ml - glykopyrroniumbromidi